Saving Time and Money with Transporter Studies
Dominic Surry, Associate Director of In Vitro Screening & Profiling at AstraZeneca, joins Helen Winsor from Pharma IQ, to discuss clinically relevant drug transporters. He explains the importance of exploring and understanding the forthcoming FDA/EMA regulations in order to develop transporter assays and identify transporter substrates, establish IVIVC and evaluate the clinical relevance. During the interview, he predicts which families of transporters will be the most important for drug d...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.